Evofem Biosciences EVFM Stock
0.02 USD
{{ price }}
-5.362779%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
Other OTC
Market Cap
689.09K USD
LOW - HIGH [24H]
0.01
-
0.02 USD
VOLUME [24H]
1.05M USD
{{ volume }}
P/E Ratio
0.29
Earnings per share
0.05 USD
Evofem Biosciences Price Chart
Evofem Biosciences EVFM Financial and Trading Overview
| Evofem Biosciences stock price | 0.02 USD |
| Previous Close | 1.25 USD |
| Open | 0.94 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 3100 |
| Day's Range | 0.91 - 1.5 USD |
| 52 Week Range | 0.85 - 196.25 USD |
| Volume | 51.77K USD |
| Avg. Volume | 37.18K USD |
| Market Cap | 215.96M USD |
| Beta (5Y Monthly) | -1.237508 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.8 USD |
EVFM Valuation Measures
| Enterprise Value | 71.79M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8181818 |
| PEG Ratio (5 yr expected) | 0 |
| Price/Sales (ttm) | 12.826572 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.264 |
| Enterprise Value/EBITDA | -0.864 |
Trading Information
Evofem Biosciences Stock Price History
| Beta (5Y Monthly) | -1.237508 |
| 52-Week Change | -97.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 196.25 USD |
| 52 Week Low | 0.85 USD |
| 50-Day Moving Average | 1.96 USD |
| 200-Day Moving Average | 9.58 USD |
EVFM Share Statistics
| Avg. Volume (3 month) | 37.18K USD |
| Avg. Daily Volume (10-Days) | 24.75K USD |
| Shares Outstanding | 215.96M |
| Float | 215.73M |
| Short Ratio | 0.19 |
| % Held by Insiders | 0.13% |
| % Held by Institutions | 4.46% |
| Shares Short | 8.68M |
| Short % of Float | 11.00% |
| Short % of Shares Outstanding | 10.97% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:125 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -499.63% |
| Gross Margin | 73.77% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -155.38% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 16.84M USD |
| Revenue Per Share (ttm) | 0.29 USD |
| Quarterly Revenue Growth (yoy) | -94.89% |
| Gross Profit (ttm) | 12.42M USD |
| EBITDA | -83109000 USD |
| Net Income Avi to Common (ttm) | -78014000 USD |
| Diluted EPS (ttm) | -1.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.77M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 71.13M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.135 |
| Book Value Per Share (mrq) | -0.583 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -70410000 USD |
| Levered Free Cash Flow (ttm) | -37986876 USD |
Profile of Evofem Biosciences
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 7770 Regents Roas |
| ZIP | 92122 |
| Phone | 858 550 1900 |
| Website | https://www.evofem.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 35 |
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Q&A For Evofem Biosciences Stock
What is a current EVFM stock price?
Evofem Biosciences EVFM stock price today per share is 0.02 USD.
How to purchase Evofem Biosciences stock?
You can buy EVFM shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evofem Biosciences?
The stock symbol or ticker of Evofem Biosciences is EVFM.
Which industry does the Evofem Biosciences company belong to?
The Evofem Biosciences industry is Biotechnology.
How many shares does Evofem Biosciences have in circulation?
The max supply of Evofem Biosciences shares is 45.94M.
What is Evofem Biosciences Price to Earnings Ratio (PE Ratio)?
Evofem Biosciences PE Ratio is 0.29999998 now.
What was Evofem Biosciences earnings per share over the trailing 12 months (TTM)?
Evofem Biosciences EPS is 0.05 USD over the trailing 12 months.
Which sector does the Evofem Biosciences company belong to?
The Evofem Biosciences sector is Healthcare.
Evofem Biosciences EVFM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
- {{ link.label }} {{link}}